The European Medicine Agency has recommended marketing authorization for a hybrid colchicine medicine for secondary prevention of atherothrombotic events in adults with stable coronary disease.

A recent study suggests that perimenopause offers a “window of opportunity” for females to reassess cardiovascular risk and ...

Cardiology attracted me because it was a logical specialty. At that time, it was relatively limited, and we often thought in ...

Cardiomyopathy is a group of diseases that weaken the heart muscle and are a leading cause of heart failure and sudden ...

Cardiovascular disease remains the leading cause of death among women worldwide, with risk increasing significantly after ...

Evidence that major communicable diseases, including influenza, pneumococcus, and COVID-19, can lead to cardiovascular disease has prompted the European Society of Cardiology (ESC) to issue a ...

This month: questionable value of management consultants, BP across the lifespan, patient frailty perspectives in HF, and more.

Through the work of the American Heart Association strides are being made to prevent, treat and manage heart disease.

Share on Pinterest Heart disease is the leading cause of death for both males and females, despite the myth that heart disease is a “man’s disease.” Marco Govel/Stocksy Most women are unaware of their ...

Cardiovascular prevention and proximity care are at the center of Ospedale San Carlo di Nancy’s participation in the 93rd ...